p16INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB

被引:70
作者
Zhang, SL
Qian, XL
Redman, C
Bliskovski, V
Ramsay, ES
Lowy, DR
Mock, BA
机构
[1] NCI, Ctr Canc Res, Genet Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Ctr Canc Res, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA
关键词
p16; promoter; RREB; plasmacytoma; NIH; 3T3;
D O I
10.1038/sj.onc.1206257
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BALB/c mice are susceptible to the development of pristane-induced plasma cell tumors, and have a rare allelic variant in the coding region of the p16(INK4a) (p16) tumor suppressor gene that produces a protein with impaired activity. We have now found that the BALB/c p16 promoter has an allelic variant that may also compromise p16 activity. Following pristane treatment, BALB/c p16 mRNA levels in B cells were lower than that in DBA/2 or C.D2-Petr1, a resistant BALB/c congenic strain that harbors DBA/2 chromatin surrounding the p16 locus. Four sequence variants were found between BALB/c and DBA/2 in the p16 promoter region. In reporter assays, the DBA promoter was at least four times more active in driving luciferase expression than the BALB/c promoter. Most of the difference in activity was localized to a single nucleotide deletion in BALB/c. This deletion created a consensus binding site for RREB, a ras-responsive transcriptional element with zinc-finger binding motifs. Transient transfections with RREB confirmed that the p16 promoter can be downregulated by RREB, in a Ras- or Mek-dependent manner, and that the BALB/c promoter is more sensitive than DBA/2 to regulation by RREB. BALB/c mice have both regulatory and coding region defects that may contribute to the impairment of p16 gene function.
引用
收藏
页码:2285 / 2295
页数:11
相关论文
共 41 条
[1]   Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a [J].
Alani, RM ;
Young, AZ ;
Shifflett, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7812-7816
[2]  
Anborgh PH, 1999, MOL CELL BIOL, V19, P4611
[3]   Altered methylation patterns in cancer cell genomes: Cause or consequence? [J].
Baylin, S ;
Bestor, TH .
CANCER CELL, 2002, 1 (04) :299-305
[4]  
BOTTORFF D, 1995, MOL CELL BIOL, V15, P5113
[5]   An acute phase response factor NF-kappa B site downstream of the junB gene that mediates responsiveness to interleukin-6 in a murine plasmacytoma [J].
Brown, RT ;
Ades, IZ ;
Nordan, RP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) :31129-31135
[6]   Germline CDKN2A mutation implicated in predisposition to multiple myeloma [J].
Dilworth, D ;
Liu, L ;
Stewart, AK ;
Berenson, JR ;
Lassam, N ;
Hogg, D .
BLOOD, 2000, 95 (05) :1869-1871
[7]   FUNCTIONAL INTERACTIONS OF THE RETINOBLASTOMA PROTEIN WITH MAMMALIAN D-TYPE CYCLINS [J].
EWEN, ME ;
SLUSS, HK ;
SHERR, CJ ;
MATSUSHIME, H ;
KATO, JY ;
LIVINGSTON, DM .
CELL, 1993, 73 (03) :487-497
[8]   THE RETINOBLASTOMA GENE-PRODUCT REGULATES PROGRESSION THROUGH THE G1 PHASE OF THE CELL-CYCLE [J].
GOODRICH, DW ;
WANG, NP ;
QIAN, YW ;
LEE, EYHP ;
LEE, WH .
CELL, 1991, 67 (02) :293-302
[9]  
Herzog CR, 1999, MOL CARCINOGEN, V25, P92, DOI 10.1002/(SICI)1098-2744(199906)25:2<92::AID-MC3>3.0.CO
[10]  
2-2